Prot #20100031: NU 16B09: A Phase II, Open label Study to evaluate Denosumab in patients with ER and/or PR-positive, HER2-negative Metastatic Breast Cancer (MBC) with bone metastases and detectable circulating tumor cells (CTCs)

  • Jain, Sarika (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/23/17 → 2/23/20

Funding

  • Amgen, Inc. (Prot #20100031)